Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tramadol for osteoarthritis.

M S Cepeda1, F Camargo, C Zea

  • 1Javeriana University School of Medicine, Department of Anesthesia, Cra 4- 70 -69, Bogota, Colombia. scepeda@javeriana.edu.co

The Cochrane Database of Systematic Reviews
|July 21, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perioperative transfusion management in craniotomies: A national survey, a starting point for the evaluation of improvements in health care.

Revista espanola de anestesiologia y reanimacion..·2024
Same author

Erratum: Publisher's Note: "Skin-on-a-chip models: General overview and future perspectives" [APL Bioengineering <b>5</b>, 030901 (2021)].

APL bioengineering·2021
Same author

Skin-on-a-chip models: General overview and future perspectives.

APL bioengineering·2021
Same author

A new microfluidic method enabling the generation of multi-layered tissues-on-chips using skin cells as a proof of concept.

Scientific reports·2021
Same author

Consensus document for multimodal intraoperatory neurophisiological monitoring in neurosurgical procedures. Basic fundamentals.

Revista espanola de anestesiologia y reanimacion·2020
Same author

Postoperative circuits in patients undergoing elective craniotomy. A narrative review.

Revista espanola de anestesiologia y reanimacion·2020

Tramadol offers modest pain relief and functional improvement for osteoarthritis, but adverse events frequently lead to discontinuation. This highlights a trade-off between small benefits and potential harm in pain management.

Area of Science:

  • Pharmacology and Pain Management
  • Rheumatology and Osteoarthritis Treatment

Background:

  • Tramadol is a pain reliever increasingly used for osteoarthritis.
  • Unlike NSAIDs, tramadol avoids gastrointestinal bleeding, renal issues, and articular cartilage damage.

Purpose of the Study:

  • To assess the analgesic effectiveness of oral tramadol in osteoarthritis patients.
  • To evaluate tramadol's impact on physical function, duration of benefit, and safety profile.

Main Methods:

  • Systematic review and meta-analysis of randomized controlled trials (RCTs).
  • Searched databases (CENTRAL, MEDLINE, EMBASE, LILACS) up to August 2005.
  • Included RCTs comparing tramadol or tramadol/paracetamol against placebo or active controls.

Main Results:

Related Experiment Videos

  • Tramadol significantly reduced pain intensity by 8.5 units (12% decrease) compared to placebo.
  • Increased likelihood of moderate improvement (NNT=6) but also elevated risk of minor (2.27x) and major (2.6x) adverse events.
  • Approximately 1 in 8 patients discontinued tramadol due to adverse events (NNTH=8).

Conclusions:

  • Tramadol provides small benefits in pain reduction and functional improvement for osteoarthritis.
  • Adverse events, though generally reversible, often limit tramadol's clinical utility.
  • Further research is needed to compare tramadol with other pharmacological treatments for osteoarthritis.